Clavis, DNO, East Capital, Kone, Vestas: Nordic Stock Preview
The following companies’ shares may have unusual price changes in Nordic trading. Stock symbols are in parentheses and share prices are from the previous close.
The Stoxx Nordic 30 Index, the benchmark measure for the region, fell 0.4 percent to 7,080.27 in Stockholm, paring the 1 percent gain on Nov. 9.
Clavis Pharma ASA (CLAVIS NO): The Norwegian cancer drug development company signed a $205 million deal with Clovis Oncology for the development and commercialization of anti- cancer agent CP-4126 in Asia and rest of the world. The shares fell 1.8 percent to 38.2 kroner.
DNO International ASA (DNO NO): The Norwegian oil company reported a third-quarter net loss of $146 million. Analysts estimated a loss of $118 million. The shares rose 3.6 percent to 9.11 kroner.
East Capital Explorer AB (ECEX SS): The Swedish investment company reported a third-quarter net income of 28 million euros compared with 41 million euros a year earlier. The shares slipped 1.3 percent to 75.25 kronor.
Kone Oyj (KNEBV FH): The Finnish company that supplies elevators to the London Underground and the Grand Mosque in Mecca was raised to “neutral” from “sell” at UBS AG. The shares fell less than 0.1 percent to 40.11 euros.
Vestas Wind Systems A/S (VWS DC): The world’s largest maker of wind turbines will increase production in the U.S. even after analysts including HSBC Holdings Plc cut forecasts for installations in the region. The shares fell 2.4 percent to 173.5 kroner.
To contact the editor responsible for this story: David Merritt at email@example.com.